Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Antidepressant Drugs: MAOIs and Other Agents01:23

Antidepressant Drugs: MAOIs and Other Agents

806
Atypical antidepressants, including bupropion (Wellbutrin), mirtazapine (Remeron), nefazodone (Serzone), trazodone (Desyrel), and vilazodone (Viibryd), offer unique mechanisms of action. Bupropion weakly inhibits dopamine and norepinephrine reuptake, aiding depression treatment and smoking cessation, with a low risk of sexual dysfunction. Mirtazapine enhances serotonin and norepinephrine neurotransmission, leading to sedation, increased appetite, and weight gain. As a result, it helps treat...
806
Treatment Strategies for Psychological Disorders01:24

Treatment Strategies for Psychological Disorders

721
Treatment approaches for psychological disorders fall into three main categories: psychological, biological, and sociocultural. Each approach targets different aspects of mental health, requiring varying levels of education and training.
Psychological therapies focus on modifying emotions, thoughts, and behaviors through talking, interpreting, listening, rewarding, challenging, and modeling. Clinical psychologists, counselors, and social workers commonly practice psychotherapy. Clinical...
721
Depression: Overview01:18

Depression: Overview

777
Depression is a prevalent mental illness marked by persistent sadness and lack of interest in previously enjoyable activities. It can take several forms, including major depression, persistent depressive disorder, and bipolar I and II disorders. Symptoms range from emotional changes like chronic worry to physical changes like sleep disturbances and suicidal thoughts. From a neurobiological perspective, depression is believed to be triggered by abnormalities in the brain's prefrontal cortex,...
777
Antidepressant Drugs: Overview01:25

Antidepressant Drugs: Overview

1.4K
Antidepressant drugs are a class of medications primarily used for treating various mood disorders, including major depression, anxiety disorders, and other related conditions. These medicines work by modulating the neurotransmitter balance within the brain, alleviating depressive symptoms. Antidepressants can be broadly categorized into several groups according to their mechanism of action and chemical structure: Selective Serotonin Reuptake Inhibitors (SSRIs), Serotonin-Norepinephrine...
1.4K
Electroconvulsive Therapy01:30

Electroconvulsive Therapy

864
Electroconvulsive therapy (ECT), or shock therapy, remains a critical biomedical intervention for severe, treatment-resistant depression. While its origins can be traced back to Hippocrates' observations that malaria-induced convulsions alleviated mental illness, modern ECT has evolved significantly from its earlier, more primitive applications. First introduced in 1938 by Ugo Cerletti and his colleagues, ECT involves inducing controlled seizures using electrical currents. In its early...
864
Depressive Disorders: Etiology01:27

Depressive Disorders: Etiology

437
Depressive disorders result from a complex interplay of biological, psychological, and sociocultural factors, each contributing uniquely to the development and persistence of the condition. Understanding these factors provides critical insight into the multifaceted nature of depression.
Biological Factors in Depression
Biological predispositions significantly influence the risk of developing depressive disorders. Genetic studies highlight the role of variations in the serotonin transporter...
437

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

ClassPass Memberships to Improve Well-Being Among Psychiatry Residents: A Pilot Randomized Controlled Trial.

Academic psychiatry : the journal of the American Association of Directors of Psychiatric Residency Training and the Association for Academic Psychiatry·2026
Same author

Educational Outcomes of a Longitudinal Women's Reproductive Mental Health Elective in Psychiatry Residency Training.

Academic psychiatry : the journal of the American Association of Directors of Psychiatric Residency Training and the Association for Academic Psychiatry·2026
Same author

Implicit Bias and Recognition of Biases Among Vascular Surgeons.

The Journal of surgical research·2026
Same author

Health Ratings and Unmet Transportation Needs in Indiana's Aged and Disabled Home and Community-Based Services Waiver Program.

Journal of aging & social policy·2025
Same author

Implicit Racial Bias and Unintentional Harm in Vascular Care.

JAMA surgery·2025
Same author

"Don't Give Up, Advocate for Yourself": A Pilot Study Examining Healthcare Experiences of People with Mayer Rokitansky Küster Hauser Syndrome.

Journal of pediatric and adolescent gynecology·2024
Same journal

Management of hypertensive disorders in pregnancy.

Current opinion in obstetrics & gynecology·2026
Same journal

Updates in group prenatal care research.

Current opinion in obstetrics & gynecology·2026
Same journal

Complex benign gynecology in perimenopause: current evidence and future directions.

Current opinion in obstetrics & gynecology·2026
Same journal

Role of insulin in female reproduction.

Current opinion in obstetrics & gynecology·2026
Same journal

Urinary tract involvement in endometriosis: current evidence and clinical insights into navigating diagnosis and management.

Current opinion in obstetrics & gynecology·2026
Same journal

Updates in ultrasound imaging of adenomyosis and clinical impacts.

Current opinion in obstetrics & gynecology·2026
See all related articles

Related Experiment Video

Updated: Jan 15, 2026

Using a Murine Model of Psychosocial Stress in Pregnancy as a Translationally Relevant Paradigm for Psychiatric Disorders in Mothers and Infants
06:39

Using a Murine Model of Psychosocial Stress in Pregnancy as a Translationally Relevant Paradigm for Psychiatric Disorders in Mothers and Infants

Published on: June 13, 2021

3.5K

Current treatment options for perinatal depression.

Ashley Clark1, Lauren D'Andrea, Alison Reminick

  • 1Department of Psychiatry, University of California San Diego, La Jolla, California, USA.

Current Opinion in Obstetrics & Gynecology
|January 14, 2026
PubMed
Summary
This summary is machine-generated.

Perinatal depression (PND) screening and treatment are crucial for maternal health. New therapies and digital tools offer improved outcomes for parents and infants, but require careful integration.

Keywords:
neurosteroidsperinatal depressionpostpartum depressionselective serotonin reuptake inhibitorszuranolone

More Related Videos

Clinical Practice Protocol of Creative Music Therapy for Preterm Infants and Their Parents in the Neonatal Intensive Care Unit
11:50

Clinical Practice Protocol of Creative Music Therapy for Preterm Infants and Their Parents in the Neonatal Intensive Care Unit

Published on: January 7, 2020

27.5K
Assessment and Evaluation of the High Risk Neonate: The NICU Network Neurobehavioral Scale
19:15

Assessment and Evaluation of the High Risk Neonate: The NICU Network Neurobehavioral Scale

Published on: August 25, 2014

87.5K

Related Experiment Videos

Last Updated: Jan 15, 2026

Using a Murine Model of Psychosocial Stress in Pregnancy as a Translationally Relevant Paradigm for Psychiatric Disorders in Mothers and Infants
06:39

Using a Murine Model of Psychosocial Stress in Pregnancy as a Translationally Relevant Paradigm for Psychiatric Disorders in Mothers and Infants

Published on: June 13, 2021

3.5K
Clinical Practice Protocol of Creative Music Therapy for Preterm Infants and Their Parents in the Neonatal Intensive Care Unit
11:50

Clinical Practice Protocol of Creative Music Therapy for Preterm Infants and Their Parents in the Neonatal Intensive Care Unit

Published on: January 7, 2020

27.5K
Assessment and Evaluation of the High Risk Neonate: The NICU Network Neurobehavioral Scale
19:15

Assessment and Evaluation of the High Risk Neonate: The NICU Network Neurobehavioral Scale

Published on: August 25, 2014

87.5K

Area of Science:

  • Obstetrics and Gynecology
  • Psychiatry
  • Maternal-Fetal Medicine

Background:

  • Perinatal depression (PND) affects a significant portion of patients, contributing to maternal mortality.
  • Despite its prevalence, PND remains underdiagnosed and undertreated, highlighting a critical gap in maternal healthcare.
  • This review synthesizes current knowledge on PND screening, treatment, and novel therapeutic approaches.

Purpose of the Study:

  • To provide an updated, clinically relevant review of perinatal depression.
  • To synthesize current evidence on screening methods, established treatments, and emerging therapies for PND.
  • To inform clinical practice regarding the diagnosis and management of PND.

Main Methods:

  • Systematic review of current literature and clinical guidelines.
  • Analysis of recent findings on pharmacological and non-pharmacological treatments for PND.
  • Evaluation of emerging technologies and interventional psychiatry for PND management.

Main Results:

  • Universal screening for PND using validated tools is recommended.
  • Selective serotonin reuptuptake inhibitors are first-line treatments, with demonstrated safety during pregnancy and lactation.
  • Emerging treatments include the neurosteroid zuranolone for rapid postpartum depression relief, and interventional psychiatry options like ketamine and TMS for select patients.
  • Digital tools and AI show potential for early detection and personalized interventions, pending further validation.

Conclusions:

  • Individualized, evidence-based treatment is essential for optimizing maternal and neonatal outcomes in PND.
  • A combination of pharmacologic and non-pharmacologic interventions can significantly improve outcomes for both parent and child.
  • New therapeutic agents and digital innovations hold promise for PND care but necessitate careful clinical integration.